Stifel Financial
TARS icon

Stifel Financial’s Tarsus Pharmaceuticals TARS Stock Holding History

Stifel Financial’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$589K Buy
9,357
+1,878
+25% +$120K ﹤0.01% 2873
2026
Q1 		$525K Buy
7,479
+676
+10% +$47.2K ﹤0.01% 2852
2025
Q4 		$557K Buy
+6,803
New +$508K ﹤0.01% 2798

Other funds holding TARS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jennison Associates
Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Stifel Financial's TARS Position: Q2 2026 in Review

Stifel Financial increased its Tarsus Pharmaceuticals (TARS) stake by 25% in Q2 2026, buying an estimated $120K and bringing the position to 9,357 shares worth $589K. The position accounts for ﹤0.01% of the portfolio, ranked #2873.

Stifel Financial first reported a position in TARS in Q4 2025 and has held it in 3 quarters since. 257 funds tracked by Wall St. Rank hold TARS as of Q2 2026.

  • Stifel Financial held 9,357 shares of Tarsus Pharmaceuticals worth $589K as of Q2 2026.
  • Stifel Financial bought 1,878 Tarsus Pharmaceuticals shares in Q2 2026, an estimated $120K.
  • Tarsus Pharmaceuticals made up ﹤0.01% of Stifel Financial's portfolio in Q2 2026, its #2873 holding.
  • Stifel Financial first reported a position in Tarsus Pharmaceuticals in Q4 2025 and has held it in 3 quarters since.
  • 257 funds tracked by Wall St. Rank held Tarsus Pharmaceuticals as of Q2 2026.

Based on Stifel Financial's 13F filing for Q2 2026, filed 12 Aug 2026.